Sfoglia per Rivista JAMA ONCOLOGY
Activity and safety of cetuximab plus modified folfoxiri followed by maintenance with cetuximab or bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer a randomized phase 2 clinical trial
2018 Cremolini, C.; Antoniotti, C.; Lonardi, S.; Aprile, G.; Bergamo, F.; Masi, G.; Grande, R.; Tonini, G.; Mescoli, C.; Cardellino, G. G.; Coltelli, L.; Salvatore, Lisa; Corsi, Domenico Cristiano; Lupi, C.; Gemma, D.; Ronzoni, M.; Dell'Aquila, E.; Marmorino, F.; Di Fabio, F.; Mancini, M. L.; Marcucci, L.; Fontanini, G.; Zagonel, V.; Boni, L.; Falcone, A.
Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors: Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic Trial
2023 Schram, Alison M; Colombo, Nicoletta; Arrowsmith, Edward; Narayan, Vivek; Yonemori, Kan; Scambia, Giovanni; Zelnak, Amelia; Bauer, Todd M; Jin, Ning; Ulahannan, Susanna V; Colleoni, Marco; Aftimos, Philippe; Donoghue, Mark T A; Rosen, Ezra; Rudneva, Vasilisa A; Telli, Melinda L; Domchek, Susan M; Galsky, Matthew D; Hoyle, Margaret; Chappey, Colombe; Stewart, Ross; Blake-Haskins, John A; Yap, Timothy A
External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors Into O-RADS Risk Groups
2023 Timmerman, Stefan; Valentin, Lil; Ceusters, Jolien; Testa, Antonia Carla; Landolfo, Chiara; Sladkevicius, Povilas; Van Holsbeke, Caroline; Domali, Ekaterini; Fruscio, Robert; Epstein, Elisabeth; Franchi, Dorella; Kudla, Marek J; Chiappa, Valentina; Alcazar, Juan L; Leone, Francesco P G; Buonomo, Francesca; Coccia, Maria Elisabetta; Guerriero, Stefano; Deo, Nandita; Jokubkiene, Ligita; Kaijser, Jeroen; Scambia, Giovanni; Andreotti, Rochelle; Timmerman, Dirk; Bourne, Tom; Van Calster, Ben; Froyman, Wouter
Hyperprogressive Disease in Patients with Advanced Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors or with Single-Agent Chemotherapy
2018 Besse, B.; Ferrara, R.; Mezquita, L.; Texier, M.; Lahmar, J.; Audigier-Valette, C.; Tessonnier, L.; Mazieres, J.; Zalcman, G.; Brosseau, S.; Le Moulec, S.; Leroy, L.; Duchemann, B.; Lefebvre, C.; Veillon, R.; Westeel, V.; Koscielny, S.; Champiat, S.; Ferte, C.; Planchard, D.; Remon, J.; Boucher, M. -E.; Gazzah, A.; Adam, J.; Bria, Emilio; Tortora, Giampaolo; Soria, J. -C.; Caramella, C.
Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma: Analysis of REACH Trial Results by Child-Pugh Score
2016 Zhu, Andrew X; Baron, Ari David; Malfertheiner, Peter; Kudo, Masatoshi; Kawazoe, Seiji; Pezet, Denis; Weissinger, Florian; Brandi, Giovanni; Barone, Carlo Antonio; Okusaka, Takuji; Wada, Yoshiyuki; Park, Joon Oh; Ryoo, Baek Yeol; Cho, Jae Yong; Chung, Hyun Cheol; Li, Chung Pin; Yen, Chia Jui; Lee, Kuan Der; Chang, Shao Chun; Yang, Ling; Abada, Paolo B; Chau, Ian
| Data di pubblicazione | Titolo | Autore(i) | File |
|---|---|---|---|
| 1-gen-2018 | Activity and safety of cetuximab plus modified folfoxiri followed by maintenance with cetuximab or bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer a randomized phase 2 clinical trial | Cremolini, C.; Antoniotti, C.; Lonardi, S.; Aprile, G.; Bergamo, F.; Masi, G.; Grande, R.; Tonini, G.; Mescoli, C.; Cardellino, G. G.; Coltelli, L.; Salvatore, Lisa; Corsi, Domenico Cristiano; Lupi, C.; Gemma, D.; Ronzoni, M.; Dell'Aquila, E.; Marmorino, F.; Di Fabio, F.; Mancini, M. L.; Marcucci, L.; Fontanini, G.; Zagonel, V.; Boni, L.; Falcone, A. | |
| 1-gen-2023 | Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors: Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic Trial | Schram, Alison M; Colombo, Nicoletta; Arrowsmith, Edward; Narayan, Vivek; Yonemori, Kan; Scambia, Giovanni; Zelnak, Amelia; Bauer, Todd M; Jin, Ning; Ulahannan, Susanna V; Colleoni, Marco; Aftimos, Philippe; Donoghue, Mark T A; Rosen, Ezra; Rudneva, Vasilisa A; Telli, Melinda L; Domchek, Susan M; Galsky, Matthew D; Hoyle, Margaret; Chappey, Colombe; Stewart, Ross; Blake-Haskins, John A; Yap, Timothy A | |
| 1-gen-2023 | External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors Into O-RADS Risk Groups | Timmerman, Stefan; Valentin, Lil; Ceusters, Jolien; Testa, Antonia Carla; Landolfo, Chiara; Sladkevicius, Povilas; Van Holsbeke, Caroline; Domali, Ekaterini; Fruscio, Robert; Epstein, Elisabeth; Franchi, Dorella; Kudla, Marek J; Chiappa, Valentina; Alcazar, Juan L; Leone, Francesco P G; Buonomo, Francesca; Coccia, Maria Elisabetta; Guerriero, Stefano; Deo, Nandita; Jokubkiene, Ligita; Kaijser, Jeroen; Scambia, Giovanni; Andreotti, Rochelle; Timmerman, Dirk; Bourne, Tom; Van Calster, Ben; Froyman, Wouter | |
| 1-gen-2018 | Hyperprogressive Disease in Patients with Advanced Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors or with Single-Agent Chemotherapy | Besse, B.; Ferrara, R.; Mezquita, L.; Texier, M.; Lahmar, J.; Audigier-Valette, C.; Tessonnier, L.; Mazieres, J.; Zalcman, G.; Brosseau, S.; Le Moulec, S.; Leroy, L.; Duchemann, B.; Lefebvre, C.; Veillon, R.; Westeel, V.; Koscielny, S.; Champiat, S.; Ferte, C.; Planchard, D.; Remon, J.; Boucher, M. -E.; Gazzah, A.; Adam, J.; Bria, Emilio; Tortora, Giampaolo; Soria, J. -C.; Caramella, C. | |
| 1-gen-2016 | Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma: Analysis of REACH Trial Results by Child-Pugh Score | Zhu, Andrew X; Baron, Ari David; Malfertheiner, Peter; Kudo, Masatoshi; Kawazoe, Seiji; Pezet, Denis; Weissinger, Florian; Brandi, Giovanni; Barone, Carlo Antonio; Okusaka, Takuji; Wada, Yoshiyuki; Park, Joon Oh; Ryoo, Baek Yeol; Cho, Jae Yong; Chung, Hyun Cheol; Li, Chung Pin; Yen, Chia Jui; Lee, Kuan Der; Chang, Shao Chun; Yang, Ling; Abada, Paolo B; Chau, Ian |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile